Login to Your Account

Pfizer, Avir arrangements in hand, Basilea still hunts for additional tie-ups

By Randy Osborne
Staff Writer

Thursday, June 15, 2017

After a spate of upbeat news, Basilea Pharmaceutica International Ltd. is not slowing down, CEO Ronald Scott said, and the company is “very active in talking to potential partners for our assets at all stages.”

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription